- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03643679
Tobacco Cessation for Sexual Minorities
There is a growing body of evidence revealing disproportionately higher rates of tobacco use among sexual and gender minority (SGM) individuals, compared to their heterosexual peers. These disparities have led organizations to support the inclusion of SGM in all local, state, and national tobacco prevention and control activities. In an attempt to leverage the online milieu for health-related interventions, mobile apps have been created to support tobacco cessation. However, evidence-based apps promoted by the National Cancer Institute are unpopular, remain poorly supported, and were not studied for use by SGM persons. Commercial apps, on the other hand, have been downloaded millions of times, contain many valuable features, and enjoy better infrastructure. Unfortunately, they are not evidence-based and have not been rigorously tested.
The University of Pittsburgh (Pitt) is currently conducting a randomized controlled trial to assess the feasibility and efficacy of using the Kwit tobacco cessation app with patients at UPMC Montefiore and Presbyterian hospitals (PI: Chu). It is a pragmatic clinical trial applying a patient-centered outcomes framework to ensure that-rather than focusing only on successful cessation-the study includes measurements for quality of life, mobility, and social interactions. We propose to extend the study to underrepresented SGM young adults.
Survey measures will be adapted as needed to address issues specific to the SGM population.
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forente stater, 15213
- University of Pittsburgh
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age 18-30
- Self-identified as a sexual minority (gay, lesbian, bisexual)
- Smokers interested in cessation (>1 cigarettes/day over the past 30 days)
- Must own an Apple or Android based smartphone.
Exclusion Criteria:
- Already receiving pharmacological and/or behavioral intervention or counseling for smoking cessation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Kwit smartphone app
This arm will receive the Kwit smartphone app.
|
The Kwit smartphone app combines several popular features of tobacco cessation apps, including game-like features (e.g., unlocking achievement milestones for completing cessation-related tasks), useful statistics (e.g., money saved), and an ability to share progress with friends.
Users can actively engage with the app to track cravings or view progress, such as life expectancy gained.
A passive component notifies users when milestones have been achieved, e.g., when blood no longer contains nicotine.
Motivational messages can be actively requested at any time; they can also appear unsolicited, as when the user logs cravings.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Helpfulness, frequency of use, and ease of use of the intervention smartphone app
Tidsramme: 1-month and 3-month
|
Assessment of feasibility: Two follow-up surveys will be administered: the first, 1-month after recruitment,and the second, 3 months after recruitment. Surveys will be administered in-person. Specific questions will be asked to rate the Kwit smartphone application's feasibility, based on a combination of helpfulness, frequency of use, and ease of use. Frustrations and helpful aspects of the application will be assesses qualitatively.
Each of these responses (Q1-3) will be combined to report a single overall feasibility value. Qualitative data (Q4) will be used to modify scores as needed. |
1-month and 3-month
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Cessation (self-report)
Tidsramme: 1-month and 3-month
|
Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via two follow-up surveys (1 month and 3 months after recruitment), with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation.
The overall assessment of cessation will be primarily based on the 7-day item. |
1-month and 3-month
|
Cessation (bio-chemical)
Tidsramme: 1-month and 3-month
|
Cessation will also be verified by a breath analysis monitor.
The information will be obtained during each follow-up.
Biochemical verification will be based on a 10 COppm cutoff to determine whether or not the participant has successfully quit tobacco.
|
1-month and 3-month
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- PRO18050656
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kwit smartphone app
-
Paris Nanterre UniversityFullførtRøykeslutt | CBT | Engasjement | TeknologiakseptmodellFrankrike
-
Insel Gruppe AG, University Hospital BernUniversity of BernRekrutteringBarnefedme | Fedme hos ungdom | Fethet | Ikke-smittsom sykdom | Livsstil | Atferd, helse | Oppførsel, spisingSveits
-
Singapore Institute for Clinical SciencesRekrutteringType 2 diabetes | Svangerskapsdiabetes | Sunn livsstilSingapore
-
Click Therapeutics, Inc.FullførtLeddgikt | Irritabel tarm-syndrom | Fibromyalgi | Diabetisk nevropatiForente stater
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TilbaketrukketOndartet fast neoplasma | Sarkom | Hodgkin lymfom | Non-Hodgkin lymfom | Neoplasma i sentralnervesystemetForente stater
-
Yale UniversityNational Institute on Drug Abuse (NIDA); American Heart AssociationFullført
-
University of South CarolinaRekrutteringOvervekt og fedme | Pre-diabetesForente stater
-
Hypnalgesics, LLCTufts UniversityFullførtTannlege angst | Opioidbruk | Narkotika bruk | TannsmerterForente stater
-
University of California, San FranciscoConquer Cancer FoundationFullførtProstatakreft | Metastatisk prostatakreft | Metastatisk kastrasjonsresistent prostatakreftForente stater
-
University Hospitals Cleveland Medical CenterHar ikke rekruttert ennå